DK144708B - METHOD FOR PREPARING 21-HYDROXY-20-METHYL PREGNANCY DERIVATIVES - Google Patents

METHOD FOR PREPARING 21-HYDROXY-20-METHYL PREGNANCY DERIVATIVES Download PDF

Info

Publication number
DK144708B
DK144708B DK570578AA DK570578A DK144708B DK 144708 B DK144708 B DK 144708B DK 570578A A DK570578A A DK 570578AA DK 570578 A DK570578 A DK 570578A DK 144708 B DK144708 B DK 144708B
Authority
DK
Denmark
Prior art keywords
hydroxy
fermentation
methyl
nrrl
derivatives
Prior art date
Application number
DK570578AA
Other languages
Danish (da)
Other versions
DK144708C (en
DK570578A (en
Inventor
A Weber
M Kennecke
R Mueller
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK570578A publication Critical patent/DK570578A/en
Publication of DK144708B publication Critical patent/DK144708B/en
Application granted granted Critical
Publication of DK144708C publication Critical patent/DK144708C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • C12P33/005Degradation of the lateral chains at position 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Description

144708144708

Den foreliggende opfindelse angår en fremgangsmåde til fremstilling af 21-hydroxy-20-methylpregnanderivater med den almene formel IThe present invention relates to a process for the preparation of 21-hydroxy-20-methylpregnan derivatives of general formula I

H-zC CHo0HH-zC CHOOH

XXj 2 144708 hvori "bindingen ..... betyder en enkeltbinding eller en dobbelt= binding, ved fermentering af zoo- eller fytosteroler med en kultur af mycobacterium spec. NRRL B-3683 eller NRRL B-3805 eller varian= ter eller mutanter deraf med væsentlig samme egenskaber som nævnte mikroorgani smer.XXj 2 144708 wherein "the bond ..... means a single bond or a double = bond, by fermentation of zoo or phytosterols with a culture of mycobacterium spec. NRRL B-3683 or NRRL B-3805 or variants or mutants thereof having substantially the same properties as said microorganic pain.

Det er kendt, at kulturer af mycobacterium spec. NRRL B-3683 og NRRL B-3805 har evnen til at danne 21-hydroxy-20-methyl-pregnan-derivater med den almene formel I ud fra zoo- eller fytosteroler (Applied Microbiology 23, 1972, 72 ff. og Applied and Enviromental Microbiology 32, 1976, 310 ff.). Disse forbindelser dannes imidler= tid kun sporvis eller i meget ringe udbytter, så at den kendte fremgangsmåde næppe er teknisk anvendelig.It is known that cultures of mycobacterium spec. NRRL B-3683 and NRRL B-3805 have the ability to form 21-hydroxy-20-methyl-pregnane derivatives of the general formula I from zoo or phytosterols (Applied Microbiology 23, 1972, 72 et seq. And Applied and Enviromental Microbiology 32, 1976, 310 et seq.). These compounds, however, are formed only by trace or in very poor yields, so that the known method is hardly technically applicable.

Ved hjælp af franganganådea ifølge opfindelsen, der er ejenåcmmelig ved det i krav l's kendetegnende del angivne, kan signifikant højere udbytter af 21-hydroxy-20-methyl-pregnan-derivater med den almene formel I opnås sammenlignet med den kendte fremgangsmåde.With the aid of the present invention, which is acceptable by the characterizing part of claim 1, significantly higher yields of 21-hydroxy-20-methyl-pregnane derivatives of the general formula I can be obtained compared to the known process.

Egnede zoo- eller fytosteroler til fermenteringen er eksempelvis cholesterol, stimasterol, campesterol, brassicasterol eller sitosteroleme, 3-acylforbindel-serne, såsom eksempelvis acetaterne af disse steroler eller de ud fra 4 disse steroler ved hjælp af Oppenauer-oxidation opnåede 3-keto-A -steroider, såsem eksempelvis 4-cholesten-3-on, 4-stigmasten-3-on, 4-sitosten-3-on eller 4-=-campesten-3—on.Suitable zoo or phytosterols for the fermentation are, for example, the cholesterol, stimasterol, campesterol, brassicasterol or sitosterols, the 3-acyl compounds, such as, for example, the acetates of these sterols or the 3-keto-A obtained from Oppenauer oxidation from these 4 steroids, such as, for example, 4-cholesterol-3-one, 4-stigmasten-3-one, 4-sitosten-3-one or 4 - = - campesten-3-one.

Ved fremgangsmåden ifølge opfindelsen gennemføres fermenteringen • i nærværelse af borationer eller organiske borforbindelser. Eg= nede borforbindelser er eksempelvis borsyre, natriummetaborat, dinatriumtetraborat, calciummetaborat eller triphenylborat, Fer= menteringen gennemgøres fortrinsvis i nærværelse af 0,1% til 0,5% reagenser, der tilfører borationer. Tilsætningen af reagenserne, der tilfører borationer, foregår fortrinsvis 10 til 30 timer efter fermenteringens begyndelse.In the process of the invention, the fermentation is carried out in the presence of borations or organic boron compounds. Suitable boron compounds are, for example, boric acid, sodium metaborate, disodium tetraborate, calcium metaborate or triphenylborate. The fermentation is preferably carried out in the presence of 0.1% to 0.5% reagents which supply boron ions. The addition of the reagents supplying borations is preferably carried out 10 to 30 hours after the start of the fermentation.

Ved tilsætningen af reagenserne, som tilfører borationer, skal der sørges for, at fermenteringskulturens pH-værdi på sædvanlig måde indstilles på en værdi mellem 6,0 og 8,0.When adding the reagents which supply borations, care must be taken to adjust the pH of the fermentation culture in the usual manner to a value between 6.0 and 8.0.

I øvrigt gennemføres fermenteringen under de sædvanlige betingel= ser. Mikroorganismerne dyrkes i et passende næringsmedium under , 144708 3 beluftning af submerskulturer. Kulturerae tilsættes derpå substra= tet (opløst i et passende opløsningsmiddel og fortrinsvis i emul= geret form), og man fermenterer, indtil en maksimal substratomdan= nelse er opnået ( 96-160 timer).Moreover, the fermentation is carried out under the usual conditions. The microorganisms are grown in an appropriate nutrient medium under aeration of submersible cultures. The culture medium is then added to the substrate (dissolved in a suitable solvent and preferably in emulsified form) and fermented until a maximum substrate conversion is achieved (96-160 hours).

Egnede substratopløsningsmidler er eksempelvis methanol, ethanol, glycolmonomethylether, dime thylformamid eller dimethylsulfoxid. Emulgeringen af substratet kan eksempelvis foretages ved, at sub= stratet i mikroniseret form eller opløst i et med vand blandbart opløsningsmiddel (såsom methanol, ethanol, acetone, glycolmonome= thylether, dimethylformamid eller dimethylsulfoxid) under kraftig turbulens inddoseres i (fortrinsvis afkalket) vand, som indeholder de sædvanlige emulgeringshjælpemidler. Egnede emulgeringshjælpemid= ler er ikke-ionogene emulgatorer, såsom eksempelvis ethylenoxidad= dukter eller fedtsyreestere af polyglycoler. Som egnede emulgatorer skal eksempelvis nævnes de i handelen gåejide befugtningsmidler "Tegin" ®, "Tagat"®, "Tween"® og "Span" ®.Suitable substrate solvents are, for example, methanol, ethanol, glycol monomethyl ether, dime thylformamide or dimethyl sulfoxide. For example, the emulsification of the substrate may be effected by dosing the substrate in micronized form or dissolved in a water miscible solvent (such as methanol, ethanol, acetone, glycol monomethyl ether, dimethylformamide or dimethyl sulfoxide) under heavy turbulence in (preferably decalcified) water. which contains the usual emulsifying aids. Suitable emulsifiers are nonionic emulsifiers, such as, for example, ethylene oxide adducts or fatty acid esters of polyglycols. Suitable emulsifiers include, for example, commercially available wetting agents "Tegin" ®, “Tagat” ®, “Tween” ® and “Span” ®.

Ved fermenteringen muliggør emulgeringen af substraterne ofte en forøget substratkapacitet og således en stigning i substratkoncen= trationen. Det er imidlertid selvsagt også muligt ved fremgangsmå= den ifølge opfindelsen at anvende andre metoder til forøgelse af substratkapaciteten, således som de er velkendte for fagmanden på fermenteringsområdet.In the fermentation, the emulsification of the substrates often allows an increased substrate capacity and thus an increase in the substrate concentration. However, it is of course also possible to use other methods of increasing the substrate capacity in the process according to the invention, as are well known to those skilled in the fermentation field.

Den optimale substratkoncentration, substrattilsætningstid og fer= menteringsvarighed afhænger af strukturen af det benyttede sub= strat. Disse størrelser skal, som det almindeligvis kræves ved mi= krobiologiske steroidomdannelser, i det enkelte tilfælde fastslås ved hjælp af forudgående forsøg, således som det er velkendt for fagmanden.The optimum substrate concentration, substrate addition time and fermentation duration depend on the structure of the substrate used. These sizes, as is usually required for microbiological steroid conversions, must in each case be determined by prior experiments, as is well known to those skilled in the art.

En yderligere forøgelse af fremgangsmådeprodukterne kan opnås, når man på sædvanlig måde selekterer eller muterer mycobacteriearterne, Således kan man eksempelvis - hensigtmæssigt efter behandling med mutagener - udbrede mycobacterium spec. NRRL B-3805 på blod-agar-plader, og man opnår enkeltkolonier af forskelligt morphologisk udseende. Isolerer man disse enkeltkolonier og afprøver dem for 4 144708 deres evne til dannelse af 21-hydroxy-20-methyl-pregnan-derivater med den almene formel I, så finder man, at der især blandt selekfcions= stammerne, der danner runde kolonier, er stammer, der frembringer et 1,5 til 3 gange højere udbytte af 21-hydroxy-20-methyl-pregnan-derivater end den ikke-selekterede stamme.Further enhancement of the process products can be achieved when selecting or mutating the mycobacteria species in the usual manner. Thus, for example - appropriately after treatment with mutagens - mycobacterium spec. NRRL B-3805 on blood agar plates and single colonies of different morphological appearance are obtained. If these single colonies are isolated and tested for their ability to form 21-hydroxy-20-methyl-pregnane derivatives of general formula I, one finds that especially among the selection strains forming round colonies, there are strains producing a 1.5 to 3 times higher yield of 21-hydroxy-20-methyl-pregnane derivatives than the unselected strain.

21-hydroxy-20-methyl-pregnan-derivaterne med den almene formel I er værdifulde mellemprodukter til syntese af farmakologisk virk= somme steroider. Det er således eksempelvis muligt at oxidere disse forbindelser til de tilsvarende pregnan-20-carboxylsyrer med den almene formel III, som ved hjælp af den af H. Ruschig et al.The 21-hydroxy-20-methyl-pregnane derivatives of general formula I are valuable intermediates for the synthesis of pharmacologically active steroids. Thus, for example, it is possible to oxidize these compounds to the corresponding pregnane-20-carboxylic acids of the general formula III, which, by means of that of H. Ruschig et al.

(Chem. Ber. 88, 1955, 883 ff) beskrevne fremgangsmåde kan overføres til de tilsvarende pregnan-3,20-dion-derlvater med formlen IV.(Chem. Ber. 88, 1955, 883 et seq.) Can be transferred to the corresponding pregnane-3,20-dione derivatives of formula IV.

1 fH3 III1 fH3 III

c=o (Y = hydrogen eller 17a-hydroxy)c = o (Y = hydrogen or 17a-hydroxy)

De således opnåede forbindelser udmærker sig som bekendt ved hjælp af deres gestagene virkning og er yderligere værdifulde mellem= produkter til syntese af talrige farmakologisk virksomme steroider.The compounds thus obtained are known, as is well known, by their progestogenic action and are further valuable intermediates for the synthesis of numerous pharmacologically active steroids.

De efterfølgende eksempler tjener til nærmere belysning af opfin= del s en.The following examples serve to illustrate the invention.

Eksempel 1 a) En 2 1 Erlenmeyerkolbe med 500 ml sterilt næringsmedium - inde= 5 144708 holdende 1% gærekstrakt 0,45% dinatriumhydrogenphosphat 0,34% kaliumdihydrogenphosphat 0,2% "Tagat" ® 02 - indstillet til pH 6,7 - podes med en opslæmning af en tørkultur af mycobacterium spec.Example 1 a) A 2 1 Erlenmeyer flask with 500 ml sterile nutrient medium - inside = 5 144708 containing 1% yeast extract 0.45% disodium hydrogen phosphate 0.34% potassium dihydrogen phosphate 0.2% "Tagat" ® 02 - adjusted to pH 6.7 - grafted with a slurry of a dry culture of mycobacterium spec.

NRRL B-3805 og rystes i 3 dage med 190 omdrejninger pr. minut ved 30°C.NRRL B-3805 and shaken for 3 days at 190 rpm. per minute at 30 ° C.

b) 22 g sitosterol emulgeres med 4,4 g "Tegin" ® og 430 ml vand ved 95°C med et ultra-"Turrax" ® (firma Jahrike og Kunkel) i 25 minutter, og der fyldes op til 513 g med vand. Man steriliserer emulsionen i 20 minutter ved 120°C.b) 22 g sitosterol is emulsified with 4.4 g of Tegin® and 430 ml of water at 95 ° C with an ultra "Turrax" ® (companies Jahrike and Kunkel) for 25 minutes and make up to 513 g with water . The emulsion is sterilized for 20 minutes at 120 ° C.

c) En 500 ml Erlenmeyerkolbe med 65 ml sterilt næringsmedium - in= deholdende 2 g majsstøbevæske 0,3 g diammoniuHjhydrogenphosphat 0,25 g "Tagat" ® 02 - indstillet til pH 6,5 - podes med 5 ml af mycobacterium spec, podekulturen. Derpå tilsættes 28 ml af den som anført under lb) fremstillede suspension (dette svarer til 1,2 g sitosterol) og efter 24 timer bliver 4 ml 4% vandig na= triumtetraboratopløsning tilsat, og der fermenteres i yderligere 120 timer ved 30°C under rystning.c) A 500 ml Erlenmeyer flask with 65 ml sterile nutrient medium - containing 2 g of corn mold liquid 0.3 g of diammonylhydrogen phosphate 0.25 g of "Tagat" ® 02 - adjusted to pH 6.5 - inoculated with 5 ml of mycobacterium spec, the seed culture. Then, 28 ml of the suspension prepared as indicated in (b) is added (this corresponds to 1.2 g of sitosterol) and after 24 hours 4 ml of 4% aqueous sodium tetraborate solution is added and fermented for an additional 120 hours at 30 ° C. shaking.

Efter foretaget fermentering ekstraheres dyrkningsvæsken 2 gange, hver gang med 100 ml ethylenchlorid. De forenede ethylenchlorideks= trakter tilsættes 11 g aktivt carbon og filtreres gennem et folde= filter. Filtratet inddampes derefter ved 40°C på en rotationsfor= damper og kromatograferes på aluminiumoxid. Efter udført kromato= grafi opnår man 135 mg 21-hydroxy-20-methyl-4-pregnen-3-on med smeltepunkt 140-141°C (fra ethylacetat).After fermentation, the culture broth is extracted twice, each time with 100 ml of ethylene chloride. The combined ethylene chloride extracts are added to 11 g of activated carbon and filtered through a folding filter. The filtrate is then evaporated at 40 ° C on a rotary evaporator and chromatographed on alumina. After chromatography, 135 mg of 21-hydroxy-20-methyl-4-pregnen-3-one is obtained, mp 140-141 ° C (from ethyl acetate).

Udfører man reaktionen tander de samme betingelser, men uden til= sætning af natriumtetraboratopløsning, opnår man 45 mg 21-hydroxy- 6 UA708 20-methyl-4-pregnan-3-on.If the reaction is carried out under the same conditions, but without the addition of sodium tetraborate solution, 45 mg of 21-hydroxy-6UA708 20-methyl-4-pregnan-3-one is obtained.

Eksempel 2 a) 513 g emulsion fremstilles ud fra 22 g 4-cholesten-3-on lige= som i eksempel lb.Example 2 a) 513 g of emulsion is prepared from 22 g of 4-cholesterol-3-one equal to Example 1b.

b) under betingelserne ifølge eksempel 1c dyrkes 70 ml af en myco= bacterium spec. NRRL B-3805 kultur, tilsættes 28 ml af 4-cholesten- 3-on-emulsionen og efter 24 timer 4 ml 4%.vandig natriumtetraborat= opløsning, og der fermenteres yderligere i 120 timer ved 30°C under rystning.b) under the conditions of Example 1c, 70 ml of a myco = bacterium spec. NRRL B-3805 culture, 28 ml of the 4-cholesterol-3-one emulsion is added and after 24 hours 4 ml of 4% aqueous sodium tetraborate = solution and further fermented for 120 hours at 30 ° C with shaking.

Man oparbejder fermenteringsportionen som beskrevet i eksempel 1c og opnår 95 mg 21-hydroxy-20-methyl-4-pregnen-3-on med smeltepunkt 142-144°C.The fermentation portion is worked up as described in Example 1c and 95 mg of 21-hydroxy-20-methyl-4-pregnen-3-one is obtained, mp 142-144 ° C.

Udfører man reaktionen under de samme betingelser, men uden tilsæt= ning af natriumtetraboratopløsning, opnår man 40 mg 21-hydroxy-20-methyl-4-pregnen-3-on.If the reaction is carried out under the same conditions, but without the addition of sodium tetraborate solution, 40 mg of 21-hydroxy-20-methyl-4-pregnen-3-one is obtained.

Eksempel ,3 28 ml af den ifølge eksempel lb fremstillede sitosterol-emulsion fermenteres som beskrevet i eksempel 1c med 70 ml af en mycobac= terium spec, NRRL B-3805 kultur, hvorved man i stedet for den vandige . natriumtetraboratopløsning anvender en tilsætning af 6 ml k% cal= ciummetaboratsuspension i vand.Example 3 28 ml of the sitosterol emulsion prepared according to Example 1b is fermented as described in Example 1c with 70 ml of a mycobacterium spec, NRRL B-3805 culture, thereby substituting the aqueous one. sodium tetraborate solution uses an addition of 6 ml of k% calcium = cesium metaborate suspension in water.

Efter oparbejdning af fermenteringsportionen som beskrevet i ek= sempel 1c opnår man 120 mg 21-hydroxy-20-methyl-4-pregnen-3-on med smeltepunkt 141-143°C.After working up the fermentation portion as described in Example 1c, 120 mg of 21-hydroxy-20-methyl-4-pregnen-3-one is obtained, mp 141-143 ° C.

Eksempel 4 28 ml af den ifølge eksempel lb fremstillede sitosterol-emulsion fermenteres som beskrevet i eksempel lc med 70 ml af en mycobac= terium spec. NRRL-B-3805-kultur, idet man i stedet for den vandige natriumtetraboratopløsning anvender en tilsætning af 5 ml af en k% triphenylboratopløsning.Example 4 28 ml of the sitosterol emulsion prepared according to Example 1b is fermented as described in Example 1c with 70 ml of a mycobacterium spec. NRRL-B-3805 culture, using an addition of 5 ml of a k% triphenylborate solution instead of the aqueous sodium tetraborate solution.

7 1447087 144708

Efter oparbejdning af fermenteringsportionen som beskrevet i ek= sempel lc opnår man 125 mg 21-hydroxy-20-methyl-4-pregnen-3-on med smeltepunkt 142-143°C.After working up the fermentation portion as described in Example 1c, 125 mg of 21-hydroxy-20-methyl-4-pregnen-3-one is obtained, mp 142-143 ° C.

Eksempel 5 a) Under de samme betingelser som i eksempel la dyrkes en myco= bacterium spec. NRRL-B-3683-kultur.Example 5 a) Under the same conditions as in Example 1a a myco = bacterium spec is grown. NRRL-B-3683 culture.

b) 65 ml af det i eksempel lc beskrevne næringsmedium tilsættes 5 ml af mycobacterium spec. NRRL-B-3683-podekulturen. Kulturen til= sættes derpå 28 ml af den i eksempel lb beskrevne sitosterol-emul= sion, og efter 24 timer 4 ml 4% natriumtetraboratopløsning, og der fermenteres i yderligere 120 timer. Man oparbejder fermenteringsmæng= den som beskrevet i eksempel lc og opnår 90 mg 21-hydroxy-20-methyl- l,4-pregnadien-3-on med smeltepunkt 180-182°C (fra ethylacetat-ace= tone).b) 65 ml of the nutrient medium described in Example 1c are added 5 ml of mycobacterium spec. NRRL-B-3683-seed culture. The culture is then added 28 ml of the sitosterol emulsion described in Example 1b and after 24 hours 4 ml of 4% sodium tetraborate solution and fermented for an additional 120 hours. The fermentation amount is worked up as described in Example 1c and 90 mg of 21-hydroxy-20-methyl-1,4-pregnadien-3-one is obtained, mp 180-182 ° C (from ethyl acetate acetone).

Eksempel 6 40 ml af en podekultur af mycobacterium spec. NRRL-B-3805 - frem= stillet ifølge eksempel la - centrifugeres med 4000 omdrejninger pr. minut.Example 6 40 ml of a seed culture of mycobacterium spec. NRRL-B-3805 - prepared according to Example 1a - is centrifuged at 4000 rpm. minute.

Den således opnåede bakteriemasse vaskes derpå to gange med en til pH 6 nedpufret saltopløsning indeholdende 0,5% natriumchlorid, 0,012% magnesiumsulfat (heptahydrat) og 1,36% kaliumdihydrogen= phosphat, suspenderes i 40 ml af denne saltopløsning og tilsætteé 10 ml af en 0,5% l-methyl-3-nitro-l-nitrosoguanidin.The bacterial mass thus obtained is then washed twice with a saline buffered to pH 6 containing 0.5% sodium chloride, 0.012% magnesium sulfate (heptahydrate) and 1.36% potassium dihydrogen = phosphate, suspended in 40 ml of this saline solution and added 10 ml of a 0.5% 1-methyl-3-nitro-1-nitrosoguanidine.

Man inkuberer bakteriesuspensionen i en time ved 30°C, fracentri= fugerer bakterierne, vasker dem to gange med den ovennævnte salt= opløsning og udbreder dem på blod-agar-plader (fremstillingsfirma Oxoid Ltd., London). Af de dannede enkeltkolonier udvælges de, som danner runde kolonier, og af disse fremstilles podekulturer som beskrevet i eksempel la. Podekulturerne tjener til at gennemføre den i eksempel lc beskrevne fermentering med følgende resultat: 8 144708The bacterial suspension is incubated for one hour at 30 ° C, Fracentri = grout the bacteria, wash them twice with the above-mentioned salt = solution and spread on blood agar plates (Oxoid Ltd., London). Of the single colonies formed, those which form round colonies are selected and from these seed graft cultures are prepared as described in Example 1a. The seed cultures serve to carry out the fermentation described in Example 1c with the following result: 8 144708

Antal af afprøvede Udbytte af 21-hydroxy-20-methyl-4- selektionsstammer pregnen-3-onNumber of Yields of 21-Hydroxy-20-Methyl-4 Selection Strains Pregnen-3-One

Uden tilsætning af Med tilsætning af natriumtetraborat natriumtetraborat 19 0 - 200 mg 8 201 - 400 mg 94 401 - 600 mg 35 601 - 800 mg 7 801 - 1.000 mg 1.550 - 2.100 mg 0 1.001 - 1.020 mg 6 1.021 - 1.040 mg 1.900 - 3.000 mg 1 1.041 - 1.060 mg 2.900 mg (150 mg) 0 1.061 - 1.080 mg 1.081 - 2.000 mg 1 (195 mg) 3.450 mgWithout the addition of With the addition of sodium tetraborate sodium tetraborate 19 0 - 200 mg 8 201 - 400 mg 94 401 - 600 mg 35 601 - 800 mg 7 801 - 1,000 mg 1,550 - 2,100 mg 0 1,001 - 1,020 mg 6 1,021 - 1,040 mg 1,900 - 3,000 mg 1 1.041 - 1.060 mg 2.900 mg (150 mg) 0 1.061 - 1.080 mg 1.081 - 2.000 mg 1 (195 mg) 3.450 mg

Claims (2)

9 144708 Patentkrav.9 144708 Patent Claims. 1. Fremgangsmåde til fremstilling af 21-hydroxy-20-methylpregnan= derivater med den almene formel I h3c ch2oh (i). hvori bindingen ..... betyder en enkeltbdnding eller en dobbeltbin ding, ved fermentering af 2oo- eller fytosteroler med en kultur af mycobacterium spec. NRRL B-3683 eller NRRL B-3805 eller varianter og mutanter deraf med væsentlig samme egenskaber son nævnte mikroorganismer, kendetegnet ved, at man gennemfører fermenteringen ved en ρΠ-vaxli fra 6,0 til 8,0 i narværelse af borationer eller organiske borforbindelser.A process for the preparation of 21-hydroxy-20-methylpregnan = derivatives of the general formula I h3c ch2oh (i). wherein the bond ..... means a single bond or a double bond, by fermentation of 2OO or phytosterols with a culture of mycobacterium spec. NRRL B-3683 or NRRL B-3805 or variants and mutants thereof having substantially the same characteristics as said microorganisms, characterized in that the fermentation is carried out at a ρΠ-vaxli from 6.0 to 8.0 in the presence of borations or organic boron compounds. 2. Fremgangsmåde ifølge krav 1, kendetegnet ved, at man fermenterer en zoo- eller fytosterol med den almene formel II 3 jC (II), hvori bindingerne ..... betyder enkeltbindinger eller dobbeltbin dinger, X betegner en oxogruppe eller et hydrogenatom, og R1 betegner et hydrogenatom, en methylgruppe eller en ethylgruppe. 1 Fremgangsmåde ifølge krav 1 eller 2, kendetegnet ved, at man som reagens, der tilfører borationer, anvender ortho= borsyre, metaborsyre, polyborsyre eller alkali- eller jordalkali= metalsalte deraf.A process according to claim 1, characterized in that a zoo or phytosterol of the general formula II is fermented with the formula II 3jC (II) wherein the bonds ..... denote single bonds or double bonds, X represents an oxo group or a hydrogen atom, and R 1 represents a hydrogen atom, a methyl group or an ethyl group. A process according to claim 1 or 2, characterized in that as the reagent which supplies borations, ortho = boric acid, metaboric acid, polyboronic acid or alkali or alkaline earth metal salts thereof are used.
DK570578A 1977-12-19 1978-12-19 METHOD FOR PREPARING 21-HYDROXY-20-METHYL PREGNANCY DERIVATIVES DK144708C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19772757156 DE2757156A1 (en) 1977-12-19 1977-12-19 PROCESS FOR THE PREPARATION OF 21-HYDROXY-20-METHYL-PREGNAN DERIVATIVES
DE2757156 1977-12-19

Publications (3)

Publication Number Publication Date
DK570578A DK570578A (en) 1979-06-20
DK144708B true DK144708B (en) 1982-05-17
DK144708C DK144708C (en) 1982-10-11

Family

ID=6026798

Family Applications (1)

Application Number Title Priority Date Filing Date
DK570578A DK144708C (en) 1977-12-19 1978-12-19 METHOD FOR PREPARING 21-HYDROXY-20-METHYL PREGNANCY DERIVATIVES

Country Status (12)

Country Link
EP (1) EP0002535B1 (en)
JP (1) JPS5581A (en)
AT (1) AT363625B (en)
CS (1) CS202517B2 (en)
DD (1) DD139859A5 (en)
DE (2) DE2757156A1 (en)
DK (1) DK144708C (en)
GB (1) GB2010276B (en)
HU (1) HU181505B (en)
IE (1) IE47691B1 (en)
SU (1) SU862830A3 (en)
YU (1) YU285578A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800072A (en) * 1988-01-14 1989-01-24 Rhone Poulenc, Inc. Anhydrous cerous nitrate-ammonium nitrate complex and a process for its preparation from ceric ammonium nitrate
JP2018522054A (en) * 2015-08-07 2018-08-09 インターセプト ファーマシューティカルズ, インコーポレイテッド Process for the preparation of bile acids and their derivatives
CN111651099A (en) 2020-04-28 2020-09-11 北京载诚科技有限公司 Touch device
CN111596791A (en) 2020-04-28 2020-08-28 北京载诚科技有限公司 Touch panel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3684657A (en) * 1970-05-11 1972-08-15 Searle & Co Selective microbiological degradation of steroidal 17-alkyls
US3759791A (en) * 1970-12-10 1973-09-18 Searle & Co Selective microbiological preparation of androst-4-ene-3,17-dione

Also Published As

Publication number Publication date
GB2010276B (en) 1982-08-04
SU862830A3 (en) 1981-09-07
DK144708C (en) 1982-10-11
DE2861249D1 (en) 1981-12-10
DE2757156A1 (en) 1979-06-21
AT363625B (en) 1981-08-25
EP0002535B1 (en) 1981-09-30
YU285578A (en) 1982-10-31
IE47691B1 (en) 1984-05-30
IE782486L (en) 1979-06-19
DK570578A (en) 1979-06-20
HU181505B (en) 1983-10-28
DD139859A5 (en) 1980-01-23
EP0002535A3 (en) 1979-07-11
JPS5581A (en) 1980-01-05
JPS6350000B2 (en) 1988-10-06
CS202517B2 (en) 1981-01-30
GB2010276A (en) 1979-06-27
ATA904778A (en) 1981-01-15
EP0002535A2 (en) 1979-06-27

Similar Documents

Publication Publication Date Title
DE2558088C2 (en) Process for the preparation of 4-androstene-3,17-dione derivatives
JPH022395A (en) Microbiological production of 9 alpha-hydroxy- 17-ketosteroid
DK144708B (en) METHOD FOR PREPARING 21-HYDROXY-20-METHYL PREGNANCY DERIVATIVES
JPH02502514A (en) 1,2-Dehydrogenation of steroid 21-esters in A. simplex
US2960436A (en) Synthesis of steroids by diplodia natalensis
US4212940A (en) Process for the preparation of 21-hydroxy-20-methylpregnane derivatives
DE2534911C2 (en) Process for the preparation of 5-androsten-17-one derivatives
US3507749A (en) Process for preparing steroids
US2799690A (en) 3-keto-16alpha, 20beta-dihydroxy pregnenes
CH637993A5 (en) Process for the preparation of a mixture of androsta-1,4-diene-3,17-dione and androst-4-ene-3,17-dione
US3080298A (en) Method of 9alpha-hydroxylating steroids
RU2082762C1 (en) Process for preparing 17-oxosteroids
US5391484A (en) Process for the production of 4-pregnene-3,20-dione and its derivatives using mycobacterium NRRL B-3805
US4062880A (en) 9α-Hydroxy-bis-nor-cholanic acid
DD145280A5 (en) METHOD FOR PRODUCING ANDROST-4-EN-3,17-DION
JPS5910792B2 (en) Novel microorganism
US3452005A (en) 4-pregnene-11beta-ol-3,20-dione-(17alpha,16alpha-d)-oxazolines
JPS608120B2 (en) Method of manufacturing compounds using microorganisms
EP0027829A1 (en) Process for the preparation of 9-alpha-hydroxy-4-androstene-3,17-dione
DE2558089A1 (en) PROCESS FOR THE PRODUCTION OF ANDROSTANE-3,17-DIONE DERIVATIVES
US5429934A (en) Process for the production of 20-methyl-5,7-pregnadiene-3β,21-diol derivatives using mycobacterium
US3190809A (en) Process for the preparation of 11alpha-hydroxy-delta4-3-keto steroids from 11-unsubstituted delta5-3-hydroxy and 3-acyloxy steroids using psilocybe caerulescens var. mazatecorum
US2875133A (en) Preparation of 21-hydroxy steroids
US4431591A (en) 24-Nor-1,4-choladiene-3,22-dione
DE3248434A1 (en) METHOD FOR PRODUCING 3.11 (ALPHA) -DIHYDROXY-1,3,5 (10) -ESTRATRINE DERIVATIVES

Legal Events

Date Code Title Description
PBP Patent lapsed